retatrutide weight loss clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Eli Lilly infiltrates anti-obesity market

Constipation is a common side effect and can be severe

Persistent diarrhea that continues for a long time should not be ignored because it may increase the risk of dehydration or nutritional problems

Hernandez AF, Green JB, Janmohamed S et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial

As the research landscape evolves beyond first-generation GLP-1 agonists, retatrutides triple-agonist architecture provides a foundation for investigating metabolic flexibility, substrate utilization, and combination protocols impossible with dual-agonist or single-agonist compounds

Full transparency, I do not need the medication, so I asked for a refund, and they issued it within 24 hours